Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
Condition: Diabetes Mellitus, Type 2Interventions: Drug: INSULIN GLARGINE; Drug: metformin; Drug: repaglinide; Drug: acarbose; Drug: sitagliptinSponsor: SanofiNot yet recruiting - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acarbose | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Insulin | Lantus | Metformin | Research